Skip to main content Help with accessibility Skip to main navigation

Recommendations

This section contains a list of the policy recommendations of the Pan Mersey Area Prescribing Committee.

Reviews of the new medicines have been conducted by our pharmacists using a number of resources including National Institute for Health and Clinical Excellence (NICE) which is a Special health Authority (SHA) set up in 1999. It is used to give advice to the NHS on best clinical practice including the clinical and cost effectiveness of drugs and other treatments.

Definitions and criteria for the categorisation of medicines

Legacy Merseyside
New Cheshire and Merseyside

Transition of Commissioning Policies

On 1st July 2022 NHS Cheshire and Merseyside Integrated Care Board (ICB) became the new statutory body responsible for ensuring health care services are available to meet the reasonable needs of the people of Cheshire & Merseyside.

Until such time as a single suite of commissioning policies can be developed and adopted, NHS Cheshire and Merseyside will continue to adopt and operate the CCG policies it has inherited at Place/borough level, which means that there will be no immediate change in commissioning policy for local people resident in those Places/boroughs from what was in place prior to 1st July 2022.

NHS Cheshire and Merseyside Commissioning Policies

 

Documents

Date Added: 23 - Oct - 2019

The Pan Mersey Area Prescribing Committee recommends the prescribing of azithromycin following specialist initiation for certain chronic airway conditions in children.

Body System:
Date Added: 30 - Aug - 2023

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of BARICITINIB tablets (Olumiant®), by specialists only, for patients hospitalised due to COVID-19 (adults and children aged 2 years and over).

NHS Cheshire and Merseyside APPROVED

Date Added: 29 - Jun - 2023

The Cheshire and Merseyside Area Prescribing Group does not recommend the prescribing of CASIRIVIMAB plus IMDEVIMAB solution for infusion (Ronapreve®▼), for treating COVID-19 in accordance with NICE TA878.

NHS Cheshire and Merseyside APPROVED

Date Added: 14 - Nov - 2017

The Pan Mersey Area Prescribing Committee recommends the use of FLUENZ®▼ nasal spray in accordance with the Annual flu programme from Public Health England.

Body System:
Date Added: 26 - Jun - 2019

The Pan Mersey Area Prescribing Committee recommends the prescribing of ITRACONAZOLE, for allergic bronchopulmonary aspergillosis.

Date Added: 29 - Jun - 2023

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of NIRMATRELVIR plus RITONAVIR tablets, SOTROVIMAB solution for infusion and TOCILIZUMAB solution for infusion  by specialists only, for treating COVID-19 in accordance with NICE TA878.

NHS Cheshire and Merseyside APPROVED

Date Added: 26 - Jun - 2019

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of voriconazole or posaconazole, by GPs or specialists, for Allergic Bronchopulmonary Aspergillosis.

Date Added: 25 - Jun - 2024

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of REMDESIVIR solution for infusion, by specialists only, for treating COVID-19 in accordance with NICE TA971.

NHS Cheshire and Merseyside APPROVED

Body System:
Date Added: 21 - Nov - 2017

NHS England specialised commissining resources: the clinical reference group responsible for infectious disease has published a commissioning policy that defines access to a particular service for a cohort of patients.

Body System:
Date Added: 21 - Nov - 2017

NHS England specialised commissining resources: the clinical reference group responsible for HIV has published a commissioning policy that defines access to a particular service for a cohort of patients.

Body System:
Date Added: 26 - Jun - 2019

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of voriconazole or posaconazole, by GPs or specialists, for Allergic Bronchopulmonary Aspergillosis.